Advertisement

Related Videos

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Advertisement

Advertisement




Feb
13
Today In Oncology
Oncolytic Virus Triggers Immune System Against Glioblastoma Cells
Young-Onset Pancreatic Cancer Can Alcohol Consumption Raise Risk
ASCO and Conexiant Launch ASCO AI in Oncology
Demographic and Clinicopathologic Factors in Colorectal Adenoma Recurrence Risk
ASH Publishes Clinical Guidelines on AL Amyloidosis Diagnosis
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo